Read the latest news from Health. Watch out for current health warnings. And find out how you can have your say on issues that affect you.
On 17 January 2019, the Minister for Senior Australians and Aged Care, the Hon Ken Wyatt AM, MP announced $15 million in funding for existing Commonwealth Home Support Programme (CHSP) providers delivering home modifications services.
A public consultation is currently open on proposed changes to the recommended use of pertussis vaccines in pregnant women in the Australian Immunisation Handbook.
The Australian Institute of Health and Welfare has recently published a series of Fact Sheets on vaccine preventable diseases. They provide information about the diseases and their impact in Australia, including the number of cases reported, hospitalisations and deaths.
Human papillomavirus (HPV) vaccine doses can now be recorded on the Australian Immunisation Register (AIR). This makes it easier for healthcare providers to find information about their patient’s HPV vaccinations.
From 1 July 2018, the childhood immunisation schedule will be updated based on the advice on clinical experts.
Advice on the presence of natural rubber latex in the sheath covering the needle of the Fluad trivalent influenza vaccine. Anyone who has a severe allergy to latex should not receive Fluad.
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
Annual influenza vaccination is recommended for all persons aged 6 months and over (unless contraindicated) to reduce their chance of becoming ill with influenza.
The Australian Technical Advisory Group on Immunisation (ATAGI) has provided advice regarding alternatives during supply shortage of the adult formulations of hepatitis B vaccines.
The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice for immunisation providers regarding the administration of 2018 seasonal influenza vaccines.
The Zostavax® vaccine is now available nationally for immunisation providers for people aged 70 to 79 years under the National Immunisation Program (NIP).
The Australian Technical Advisory Group on Immunisation (ATAGI) has new advice to support school based immunisation providers with the introduction of Gardasil®9 in a 2-dose schedule from January 2018.
New access arrangements under the National Immunisation Program (NIP) to provide free catch-up vaccines for all individuals aged 10 to 19 years, and refugees and humanitarian entrants aged 20 years and over from 1 July 2017.
The shingles vaccine, Zostavax®, has been approved to be placed on the National Immunisation Program (NIP), to be provided free of charge from 1 November 2016 to people aged 70 years. There will also be a 5 year catch-up program for people aged 71 to 79 years.
The Australian Government is extending childhood immunisation arrangements for family assistance payments to increase immunisation rates of children residing in Australia.
Meningococcal B vaccine and clinical advice for immunisation providers regarding the use of Bexsero® (4CMenB). From 5 March 2014, the recombinant multicomponent meningococcal B vaccine Bexsero® (4CMenB) became available through purchase on the private market.
The Pertussis Chapter, 4.12, of the 10th Edition of the Australian Immunisation Handbook has been updated and includes two changes to recommendations in the administration of pertussis-containing vaccine.